Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation

Hiroshi Uchida, Tetsuo Maruyama, Kuniaki Ohta, Masanori Ono, Toru Arase, Maki Kagami, Hideyuki Oda, Takashi Kajitani, Hironori Asada, Yasunori Yoshimura

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: The complex molecular pathways governing implantation are unclear and ethical limitations limit studies in humans. Reversible histone acetylation regulates gene transcription and histone deacetylase inhibitors (HDACI) induce specific genes. Suberoylanilide hydroxamic acid (SAHA), a HDACI recently approved as an anti-cancer drug, induces the morphological and functional differentiation of human endometrial gland cells through up-regulation of glycodelin, a secretory phase dominant protein. Methods: We investigated whether SAHA improves implantation in an in vitro implantation assay using the human endometrial adenocarcinoma cell line, Ishikawa and the choriocarcinoma cell line, JAR. Results: In an in vitro implantation assay, JAR spheroids attached and adhered to Ishikawa cells in a time dependent manner. Glycodelin induction, following treatment with ovarian steroid hormones or SAHA, enhanced implantation. The improvement in implantation was also obtained when glycodelin was overexpressed without stimulation and was almost completely abrogated by glycodelin gene silencing. Conclusions: This study demonstrates that glycodelin is a key regulatory protein of implantation and suggests that SAHA may have a capacity to supplant steroid derivatives in the treatment of infertility.

Original languageEnglish
Pages (from-to)2615-2622
Number of pages8
JournalHuman Reproduction
Volume22
Issue number10
DOIs
Publication statusPublished - 2007 Oct

Fingerprint

Histone Deacetylase Inhibitors
Steroids
Cell Line
Choriocarcinoma
Gene Silencing
Acetylation
Histones
Infertility
Genes
Proteins
Adenocarcinoma
Up-Regulation
Glycodelin
Hormones
vorinostat
Pharmaceutical Preparations
Neoplasms

Keywords

  • Glycodelin
  • Histone deacetylase inhibitor
  • Implantation
  • SAHA

ASJC Scopus subject areas

  • Physiology
  • Developmental Biology
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation. / Uchida, Hiroshi; Maruyama, Tetsuo; Ohta, Kuniaki; Ono, Masanori; Arase, Toru; Kagami, Maki; Oda, Hideyuki; Kajitani, Takashi; Asada, Hironori; Yoshimura, Yasunori.

In: Human Reproduction, Vol. 22, No. 10, 10.2007, p. 2615-2622.

Research output: Contribution to journalArticle

Uchida, H, Maruyama, T, Ohta, K, Ono, M, Arase, T, Kagami, M, Oda, H, Kajitani, T, Asada, H & Yoshimura, Y 2007, 'Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation', Human Reproduction, vol. 22, no. 10, pp. 2615-2622. https://doi.org/10.1093/humrep/dem263
Uchida, Hiroshi ; Maruyama, Tetsuo ; Ohta, Kuniaki ; Ono, Masanori ; Arase, Toru ; Kagami, Maki ; Oda, Hideyuki ; Kajitani, Takashi ; Asada, Hironori ; Yoshimura, Yasunori. / Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation. In: Human Reproduction. 2007 ; Vol. 22, No. 10. pp. 2615-2622.
@article{569ffdb9996d41d4b8cf54601bfa69d8,
title = "Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation",
abstract = "Background: The complex molecular pathways governing implantation are unclear and ethical limitations limit studies in humans. Reversible histone acetylation regulates gene transcription and histone deacetylase inhibitors (HDACI) induce specific genes. Suberoylanilide hydroxamic acid (SAHA), a HDACI recently approved as an anti-cancer drug, induces the morphological and functional differentiation of human endometrial gland cells through up-regulation of glycodelin, a secretory phase dominant protein. Methods: We investigated whether SAHA improves implantation in an in vitro implantation assay using the human endometrial adenocarcinoma cell line, Ishikawa and the choriocarcinoma cell line, JAR. Results: In an in vitro implantation assay, JAR spheroids attached and adhered to Ishikawa cells in a time dependent manner. Glycodelin induction, following treatment with ovarian steroid hormones or SAHA, enhanced implantation. The improvement in implantation was also obtained when glycodelin was overexpressed without stimulation and was almost completely abrogated by glycodelin gene silencing. Conclusions: This study demonstrates that glycodelin is a key regulatory protein of implantation and suggests that SAHA may have a capacity to supplant steroid derivatives in the treatment of infertility.",
keywords = "Glycodelin, Histone deacetylase inhibitor, Implantation, SAHA",
author = "Hiroshi Uchida and Tetsuo Maruyama and Kuniaki Ohta and Masanori Ono and Toru Arase and Maki Kagami and Hideyuki Oda and Takashi Kajitani and Hironori Asada and Yasunori Yoshimura",
year = "2007",
month = "10",
doi = "10.1093/humrep/dem263",
language = "English",
volume = "22",
pages = "2615--2622",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation

AU - Uchida, Hiroshi

AU - Maruyama, Tetsuo

AU - Ohta, Kuniaki

AU - Ono, Masanori

AU - Arase, Toru

AU - Kagami, Maki

AU - Oda, Hideyuki

AU - Kajitani, Takashi

AU - Asada, Hironori

AU - Yoshimura, Yasunori

PY - 2007/10

Y1 - 2007/10

N2 - Background: The complex molecular pathways governing implantation are unclear and ethical limitations limit studies in humans. Reversible histone acetylation regulates gene transcription and histone deacetylase inhibitors (HDACI) induce specific genes. Suberoylanilide hydroxamic acid (SAHA), a HDACI recently approved as an anti-cancer drug, induces the morphological and functional differentiation of human endometrial gland cells through up-regulation of glycodelin, a secretory phase dominant protein. Methods: We investigated whether SAHA improves implantation in an in vitro implantation assay using the human endometrial adenocarcinoma cell line, Ishikawa and the choriocarcinoma cell line, JAR. Results: In an in vitro implantation assay, JAR spheroids attached and adhered to Ishikawa cells in a time dependent manner. Glycodelin induction, following treatment with ovarian steroid hormones or SAHA, enhanced implantation. The improvement in implantation was also obtained when glycodelin was overexpressed without stimulation and was almost completely abrogated by glycodelin gene silencing. Conclusions: This study demonstrates that glycodelin is a key regulatory protein of implantation and suggests that SAHA may have a capacity to supplant steroid derivatives in the treatment of infertility.

AB - Background: The complex molecular pathways governing implantation are unclear and ethical limitations limit studies in humans. Reversible histone acetylation regulates gene transcription and histone deacetylase inhibitors (HDACI) induce specific genes. Suberoylanilide hydroxamic acid (SAHA), a HDACI recently approved as an anti-cancer drug, induces the morphological and functional differentiation of human endometrial gland cells through up-regulation of glycodelin, a secretory phase dominant protein. Methods: We investigated whether SAHA improves implantation in an in vitro implantation assay using the human endometrial adenocarcinoma cell line, Ishikawa and the choriocarcinoma cell line, JAR. Results: In an in vitro implantation assay, JAR spheroids attached and adhered to Ishikawa cells in a time dependent manner. Glycodelin induction, following treatment with ovarian steroid hormones or SAHA, enhanced implantation. The improvement in implantation was also obtained when glycodelin was overexpressed without stimulation and was almost completely abrogated by glycodelin gene silencing. Conclusions: This study demonstrates that glycodelin is a key regulatory protein of implantation and suggests that SAHA may have a capacity to supplant steroid derivatives in the treatment of infertility.

KW - Glycodelin

KW - Histone deacetylase inhibitor

KW - Implantation

KW - SAHA

UR - http://www.scopus.com/inward/record.url?scp=34548757320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548757320&partnerID=8YFLogxK

U2 - 10.1093/humrep/dem263

DO - 10.1093/humrep/dem263

M3 - Article

C2 - 17720699

AN - SCOPUS:34548757320

VL - 22

SP - 2615

EP - 2622

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 10

ER -